• Dansk
  • NL
  • EN
  • FI
  • FR
  • DE
  • EL
  • IT
  • NO
  • PL
  • PT
  • RO
  • SL
  • ES
  • SV

What you should know about EFSA - in 3 minutes

CEO publishes a new educational tool explaining some of the major problems at EFSA, the agency responsible for scientific advice on food safety to the EU institutions.

A 3 minutes animation allows you to find out more how EFSA operates and to what extent this benefits the big food, biotech and pesticides corporations such as Monsanto, Syngenta, Unilever, Nestlé... Are EFSA's experts and management independent from industry? What role does industry play in EFSA food safety tests? Doesn't EFSA look at other, independent research on these products?

Available in English, in French and with Spanish subtitles. Please pass it on and use this widely in your networks!

EFSA animation (eng) from Corporate Europe on Vimeo.

EFSA animation (fr) from Corporate Europe on Vimeo.

EFSA animation (subtitles in Spanish) from Corporate Europe on YouTube.

For more information on conflicts of interest in EFSA and the use of independent science, see:
Exposed: Conflicts of interest among EFSA's experts on food additives

Ce que vous devez savoir sur l'EFSA - en 3 minutes.

CEO publie un nouvel outil de vulgarisation expliquant quelques-uns des principaux problèmes de l'EFSA, l'agence chargée de délivrer des recommandations scientifiques en matière de sécurité alimentaire aux autorités européennes.

Ce film d'animation de trois minutes vous permet d'en apprendre davantage sur le fonctionnement de l'EFSA et dans quelle mesure celui-ci bénéficie à l'industrie agro-alimentaire et à des multinationales des pesticides et des biotech telles que Monsanto, Syngenta, Unilever, Nestlé...

Les experts et les responsables de l'EFSA sont-ils indépendants de l'industrie? Quel rôle l'industrie joue-t-elle dans les tests sanitaires effectués par l'EFSA? L'EFSA n'utilise-t-elle pas d'autres recherches indépendantes sur ces produits?

Le film est publié en anglais et en français. N'hésitez pas à le faire circuler et à l'utiliser dans vos réseaux!

 

The European Food Safety Authority (EFSA) finally sent us the raw data of three important scientific studies it used for its evaluation of glyphosate, the "Mysterious Three". But due to legal concerns, large sections of the data have been redacted.

The European Food Safety Authority (EFSA) told CEO today, and publicly announced on their website, that they would disclose most of the raw data of studies on glyphosate used in the EU's toxicity assessment of glyphosate.

The official EU assessment of glyphosate was based on unpublished studies owned by industry. Seven months later, the pesticide industry still fights disclosure and, so far, successfully. We obtained a copy of their arguments.

The European Commission proposal on scientific criteria defining endocrine disruptors (EDCs) is the latest dangerous outgrowth of a highly toxic debate. The chemical lobby, supported by certain Commission factions (notably DG SANTE and the Secretary-General) and some member states (UK and Germany), has put significant obstacles in the way of effective public health and environment regulation.

CEO welcomes the very strongly worded final ruling by European Ombudsman Emily O'Reilly in her inquiry into the Commission's implementation of UN rules for contacts with tobacco industry lobbyists.

CEO joined forces with nine other civil society organisations working for equality, non-discrimination, transparent decision-making and strong ethics rules: in an open letter to the European Parliament we urge MEPs to oppose Oettinger’s appointment as the Comission’s head of human resources.

After nine months of hearings, the draft report of the EU Parliament's inquiry into the Dieselgate scandal has it black on white: the European Commission and EU member states had known since 2004-05 that diesel cars' nitrogen oxide emissions were far above legal limits - yet neither took action.

Our new report shows how industry lobbies present employee protection against work-related cancers as an 'unnecessary' burden on companies, and explains which tactics have been used to weaken and delay the European Union's revision of the Carcinogens and Mutagens Directive.

Subscribe to our newsletter